Search Results
You are looking at 1 - 1 of 1 items for
- Author: Andy G Lynch x
- Refine by access: Open Access content only x
Search for other papers by Charles E Massie in
Google Scholar
PubMed
Search for other papers by Inmaculada Spiteri in
Google Scholar
PubMed
Search for other papers by Helen Ross-Adams in
Google Scholar
PubMed
Search for other papers by Hayley Luxton in
Google Scholar
PubMed
Search for other papers by Jonathan Kay in
Google Scholar
PubMed
Search for other papers by Hayley C Whitaker in
Google Scholar
PubMed
Search for other papers by Mark J Dunning in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Alastair D Lamb in
Google Scholar
PubMed
Search for other papers by Antonio Ramos-Montoya in
Google Scholar
PubMed
Search for other papers by Daniel S Brewer in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Colin S Cooper in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Rosalind Eeles in
Google Scholar
PubMed
Search for other papers by UK Prostate ICGC Group in
Google Scholar
PubMed
Search for other papers by Anne Y Warren in
Google Scholar
PubMed
Search for other papers by Simon Tavaré in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by David E Neal in
Google Scholar
PubMed
Search for other papers by Andy G Lynch in
Google Scholar
PubMed
Prostate cancer is the most common cancer in men, resulting in over 10 000 deaths/year in the UK. Sequencing and copy number analysis of primary tumours has revealed heterogeneity within tumours and an absence of recurrent founder mutations, consistent with non-genetic disease initiating events. Using methylation profiling in a series of multi-focal prostate tumours, we identify promoter methylation of the transcription factor HES5 as an early event in prostate tumourigenesis. We confirm that this epigenetic alteration occurs in 86–97% of cases in two independent prostate cancer cohorts (n=49 and n=39 tumour–normal pairs). Treatment of prostate cancer cells with the demethylating agent 5-aza-2′-deoxycytidine increased HES5 expression and downregulated its transcriptional target HES6, consistent with functional silencing of the HES5 gene in prostate cancer. Finally, we identify and test a transcriptional module involving the AR, ERG, HES1 and HES6 and propose a model for the impact of HES5 silencing on tumourigenesis as a starting point for future functional studies.